Payer Intelligence: How Can It Be Combined With Technology to Enhance Patient Access?

Scott Dulitz, Chief Strategy Officer at TrialCard, discusses how combining payer intelligence with market-leading technology can enhance patient access. TrialCard recently acquired Policy Reporter, a healthcare software solutions company that provides payer intelligence to the biopharmaceutical, medical device, and diagnostics industries. To learn more, schedule a demo of Policy Reporter or contact Scott ( The healthcare industry is entering an unprecedented era of medical innovation with several recent approvals for curative cell and gene therapies, novel digital therapeutics, and market-shifting biosimilars. In parallel with these medical innovations, coverage is also shifting from fee-for-service to value-based, pay-for-performance. These industry megatrends accentuate an [...]

2020-04-19T22:27:23-04:00April 17th, 2020|

Clinical Supply Availability & Speed to Study Start-Up

The Situation If you're part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it's simple doesn't mean it's easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete. The longer it [...]

2020-03-27T14:07:37-04:00March 25th, 2020|

COVID-19: A Message from President & CEO, Mark Bouck

Over the past few weeks, all of us have been impacted by the COVID-19 pandemic. As we continue to adjust to these changing times, I wanted to update you on steps that TrialCard has taken to expand our business continuity plan. Our immediate goals are to (1) ensure the safety and well-being of our employees, (2) implement preventative measures to reduce the risk of exposure, and (3) continue to support our pharmaceutical manufacturers and their patients. We have taken aggressive steps to reduce the number of office-based employees in order to minimize risk and protect the health and safety of [...]

2020-03-24T11:40:47-04:00March 24th, 2020|

Rare is mighty. Rare is exceptional.

Rare disease is defined as affecting fewer than 200,000 people. So, there is something about the term “rare disease”….when you hear that phrase….you think of that singular patient, that very particular and unique person. In fact, every day that I begin my work in the world of rare disease, I pause and reflect on that one patient that I may be fortunate enough to help. And sometimes, our perspective can shift in wonderful ways... In January, our team had the chance to hear from a rare disease non-profit organization. Through a presentation, we were introduced to several patients being [...]

2020-03-03T14:24:31-05:00March 3rd, 2020|

Co-Pay Card Fraud Detection: The Role of Processes and People

The issue of co-pay card fraud has been in the news for some time, but with the increased prevalence of high-priced specialty products, the cost of missing this fraud – literally – has become too high for manufacturers to rely only on traditional techniques, such as human investigators.  This isn’t to say that there’s no role for people in stopping co-pay program fraud – they’re absolutely crucial!  They just can’t be the only tool used to combat fraud, as human intervention only is simply too costly and inefficient in the face of today’s fraudulent pharmacy. So if we can’t [...]

2019-10-16T13:53:37-04:00October 16th, 2019|

Asembia 2019: Key Takeaways

In May, thousands of industry players descended on the Wynn in Las Vegas for Asembia's annual Specialty Pharmacy Summit. The interactions were hot and it proved to be a great success, as it always is. As such, I wanted to take a moment to highlight what we saw at this year’s Summit as it pertains to the patient services slice of pie… Key Trends & Takeaways Co-Pay Accumulator Programs Accumulator adjustment programs deny members credit for OOP expenses that are assigned by the health plan and funded by a drug manufacturer’s coupon program. Clients are continuing to seek guidance [...]

2019-10-16T13:18:54-04:00June 3rd, 2019|

The Role of Hub Services in an Era of Drug Price Transparency, Value-Based Care, and Consumerism

Pharmaceutical manufacturer hub programs have, for many years, played a vital role in getting patients access to life-saving and life-altering medications. There is no question the value of these programs remains high, but there are emerging market dynamics that will require hub programs to evolve to continue meeting the needs of patients and healthcare providers. Drug price transparency is one of the hottest topics in the healthcare industry. In November 2018, CMS proposed a new rule focused on modernizing Part D and Medicare Advantage in order to lower drug prices and patient out-of-pocket expenses. One aspect of the proposed [...]

2019-04-23T15:47:15-04:00April 18th, 2019|

Women’s Day 2019: Balance for Better

To commemorate International Women’s Day on March 8, TrialCard’s IT Team Lead Kalindi Kapadia, a core member of our Women’s Development Group, shared her thoughts. International Women’s Day is celebrated globally each year to recognize women and their achievements. It is an occasion for each woman to acknowledge her dreams and strengths. To me, this day is about accepting myself as a woman with imperfections and flaws, and with assets and infinite capability to make a positive difference in the world. I am grateful for all the opportunities I have received, but it is important to realize that with growth [...]

2019-03-08T15:44:26-05:00March 8th, 2019|

Rare Disease Day 2019: Your Story Matters

Rare Disease Day is observed each year on the last day of February to raise awareness about little-known and overlooked diseases and to honor those families affected. Undoubtedly, individuals diagnosed with a rare disease face a multitude of obstacles and daily challenges.  Shockingly, some patients are not diagnosed until several years after initial symptoms have appeared, often even 20-25 years later! Patients’ journeys typically begin in a similar manner. Since so little information is known about the disease the patient is suffering from, they are often shuffled from physician to physician receiving no definitive answers. This results in patients [...]

2019-02-28T13:19:58-05:00February 28th, 2019|

Rare Disease Day 2019: We See You and We Care

One of the most hurtful human experiences is that of being ignored. When I contact a physician to discuss rare disease, I always say, “You may not see rare disease often, but seeing it early makes all the difference for the patient.” This is the sentiment I bring to my work every day, and the message I would like to convey to anyone with a rare disease—we see you. And even though I do not know you, I will work tirelessly on your behalf. Because you are worth it, and we know it. We see you and we care. Rare [...]

2019-02-27T16:54:43-05:00February 27th, 2019|